|
Volumn 13, Issue 6, 2000, Pages 301-305
|
Lung function improvement in smokers suffering from COPD with zafirlukast, a CysLT1-receptor antagonist
|
Author keywords
COPD; Cysteinyl leukotrienes; Salbutamol; Zafirlukast
|
Indexed keywords
LEUKOTRIENE RECEPTOR BLOCKING AGENT;
PLACEBO;
SALBUTAMOL;
ZAFIRLUKAST;
ADULT;
AGED;
AREA UNDER THE CURVE;
ARTICLE;
BRONCHODILATATION;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
DRUG POTENTIATION;
FEMALE;
HUMAN;
LUNG FUNCTION;
MALE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SMOKING;
SPIROMETRY;
|
EID: 0033675152
PISSN: 10945539
EISSN: None
Source Type: Journal
DOI: 10.1006/pupt.2000.0258 Document Type: Article |
Times cited : (31)
|
References (18)
|